MAPKs represent novel therapeutic targets for gastrointestinal motility disorders
نویسندگان
چکیده
منابع مشابه
Ion channels as targets for treatment of gastrointestinal motility disorders.
the relative lack of current drugs targeting ion channels suggests that there are also disadvantages to targeting ion channels. This is indeed the case. Disadvantages include: 1. Most ion channels are expressed in more than one cell type decreasing the ability to target organs 2. Given their critical role in cellular homeostasis, modulation can have significant side effects 3. A specific disadv...
متن کاملA Wireless Implant for Gastrointestinal Motility Disorders
Implantable functional electrical stimulation (IFES) has demonstrated its effectiveness as an alternative treatment option for diseases incurable pharmaceutically (e.g., retinal prosthesis, cochlear implant, spinal cord implant for pain relief). However, the development of IFES for gastrointestinal (GI) tract modulation is still limited due to the poorly understood GI neural network (gut–brain ...
متن کاملGastrointestinal motility disorders: an update.
Gastrointestinal motility disorders encompass a wide array of signs and symptoms that can occur anywhere throughout the luminal gastrointestinal tract. Motility disorders are often chronic in nature and dramatically affect patients' quality of life. These prevalent disorders cause a tremendous impact both to the individual patient and to society as a whole. Significant progress has been made ov...
متن کاملGastrointestinal motility disorders in children.
The most common and challenging gastrointestinal motility disorders in children include gastroesophageal reflux disease (GERD), esophageal achalasia, gastroparesis, chronic intestinal pseudo-obstruction, and constipation. GERD is the most common gastrointestinal motility disorder affecting children and is diagnosed clinically and treated primarily with acid secretion blockade. Esophageal achala...
متن کاملOctreotide in gastrointestinal motility disorders.
The effects of octreotide on six normal subjects and five patients with scleroderma were investigated. Changes in intestinal motility and in plasma motilin were examined after a single injection of octreotide. Octreotide stimulated intense intestinal motor activity in normal subjects. Motility patterns in the scleroderma patients were chaotic and non-propagative, but, after octreotide was given...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Gastrointestinal Pathophysiology
سال: 2011
ISSN: 2150-5330
DOI: 10.4291/wjgp.v2.i2.19